Trial design and objectives for castration-resistant prostate cancer: Updated recommendations from the prostate cancer clinical trials working group 3

Howard I. Scher, Michael J. Morris, Walter M. Stadler, Celestia Higano, Ethan Basch, Karim Fizazi, Emmanuel S. Antonarakis, Tomasz M. Beer, Michael A. Carducci, Kim N. Chi, Paul G. Corn, Johann S. De Bono, Robert Dreicer, Daniel J. George, Elisabeth I. Heath, Maha Hussain, Wm Kevin Kelly, Glenn Liu, Christopher Logothetis, David NanusMark N. Stein, Dana E. Rathkopf, Susan F. Slovin, Charles J. Ryan, Oliver Sartor, Eric J. Small, Matthew Raymond Smith, Cora N. Sternberg, Mary Ellen Taplin, George Wilding, Peter S. Nelson, Lawrence H. Schwartz, Susan Halabi, Philip W. Kantoff, Andrew J. Armstrong

Research output: Contribution to journal › Article › peer-review

1050 Scopus citations

Fingerprint

Dive into the research topics of 'Trial design and objectives for castration-resistant prostate cancer: Updated recommendations from the prostate cancer clinical trials working group 3'. Together they form a unique fingerprint.

Medicine & Life Sciences